Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Extension Study to Investigate the Safety of Cannabidiol (GWP42003-P; CBD) in Children and Adults With Inadequately Controlled Dravet or Lennox-Gastaut Syndromes.

NCT02224573 is registered in ClinicalTrials.gov with GW Research Ltd as lead sponsor.

NCT NCT02224573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02224573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Extension Study to Investigate the Safety of Cannabidiol (GWP42003-P; CBD) in Children and Adults With Inadequately Controlled Dravet or Lennox-Gastaut Syndromes.
Lead sponsor
GW Research Ltd
Phase
Phase 3
Overall status
Completed
Start date
June 11, 2015
Completion date
September 24, 2020
Enrollment
681 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dravet syndrome, epilepsy, lennox-gastaut syndrome